Jayant Parthasarathy

New Capabilities

Leading Certitude's national rollout

For women with dense breast tissue, a mammogram detects only about half of cancers. On September 29, Astrin Biosciences said its Certitude blood test, which flags early-stage breast cancer from a simple blood draw, is now available to 75 million women through telehealth infrastructure company OpenLoop Health.

Updated 2 hours ago